Understand the source comparison
Peptides and Low FODMAP Diet Synergy: Comparison Table
Growth Hormone Secretagogues (MK 677, Ipamorelin) Fasted. Minimum 3 hours post-meal High sensitivity to gut inflammation; FODMAP fermentation reduces IGF-1 response by 20–35% 4–6 hours (non-DAC) Schedule FODMAP challenges 12+ hours post-dose Critical timing co
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth Hormone Secretagogues (MK 677, Ipamorelin)
- Fasted. Minimum 3 hours post-meal
- High sensitivity to gut inflammation; FODMAP fermentation reduces IGF-1 response by 20–35%
- 4–6 hours (non-DAC)
- Schedule FODMAP challenges 12+ hours post-dose
- Critical timing coordination required. Inflammation during peak absorption window compromises efficacy
- Melanocortin Agonists (KPV)
- Can be dosed fed or fasted
- Directly targets gut inflammation pathways activated by FODMAP fermentation. Synergistic effect
- 2–4 hours
- Can dose concurrently with low FODMAP meals; avoid high-FODMAP challenges within 6 hours
- Strongest synergy candidate. Both interventions reduce the same inflammatory cascade
- Thymic Peptides (Thymalin)
- Fasted preferred
- Immune modulation impaired by systemic LPS from leaky gut triggered by FODMAPs
- 6–8 hours
- Schedule challenges opposite dosing cycle (morning dose → evening challenge)
- Moderate interaction. FODMAP elimination enhances immune receptor sensitivity
- Cognitive Peptides (Cerebrolysin, Dihexa)
- Fasted required
- Neuroinflammation correlates with gut inflammation; low FODMAP reduces peripheral cytokine signaling
- 4–6 hours
- Minimum 12-hour separation from FODMAP challenges
- Indirect but meaningful benefit. Gut-brain axis modulation supports peptide uptake
- Metabolic Peptides (Tesofensine, Survodutide)
- Appetite suppression and gut motility directly affected by FODMAP-induced bloating and discomfort
- 24+ hours (long half-life allows flexible timing)
- Flexibility due to extended half-life; avoid clustering challenges during titration phase
- Low interaction risk once therapeutic dose established; early titration benefits from FODMAP restriction